While the nephroprotective effects of SGLT2i were initially derived from secondary endpoints of CV outcome trials (CVOTs), direct confirmation came from dedicated kidney focused trials: CREDENCE (Perkovic et al NEJM 2019| NephJC Summary), DAPA-CKD (Heerspink et al NEJM 2020| NephJC Summary) and finally EMPAKIDNEY (Herrington et al NEJM 2023| NephJC Summary)
These stacks aim to explore synergies between complementary pathways
Zhang H, Liu M, Zhang Y, Li X
Recent trends in use of plant-derived carbon dot-based fluorescent probes for heavy metal ion detection and their biological applications
The biggest danger is when someone is ordering these medications online without any monitoring going on, and these risks and benefits havent been considered. This collaboration shouldnt end once the prescription is written
Similar to semaglutide, cyanocobalamin has relatively few side effects, and those it does have are frequently very minor